DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,451,000 | +145000.0% | 4,946 | +123550.0% | 0.09% | – |
| Q3 2020 | $1,000 | -92.9% | 4 | -94.8% | 0.00% | -100.0% |
| Q2 2020 | $14,000 | -93.7% | 77 | -95.2% | 0.01% | -95.7% |
| Q1 2020 | $222,000 | +1750.0% | 1,601 | +2034.7% | 0.16% | +2600.0% |
| Q4 2019 | $12,000 | -99.4% | 75 | -99.4% | 0.01% | -99.2% |
| Q3 2019 | $1,920,000 | +1233.3% | 13,292 | +1218.7% | 0.74% | +1358.8% |
| Q2 2019 | $144,000 | -94.0% | 1,008 | -94.5% | 0.05% | -92.2% |
| Q1 2019 | $2,403,000 | +1132.3% | 18,198 | +858.8% | 0.65% | +965.6% |
| Q4 2018 | $195,000 | -92.1% | 1,898 | -91.6% | 0.06% | -89.7% |
| Q3 2018 | $2,469,000 | +61625.0% | 22,714 | +61289.2% | 0.59% | +29450.0% |
| Q2 2018 | $4,000 | -75.0% | 37 | -77.3% | 0.00% | -75.0% |
| Q1 2018 | $16,000 | -82.8% | 163 | -83.7% | 0.01% | -83.3% |
| Q4 2017 | $93,000 | -1.1% | 1,000 | -9.1% | 0.05% | -4.0% |
| Q3 2017 | $94,000 | +1.1% | 1,100 | 0.0% | 0.05% | -13.8% |
| Q2 2017 | $93,000 | +675.0% | 1,100 | +663.9% | 0.06% | +1060.0% |
| Q3 2015 | $12,000 | 0.0% | 144 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $12,000 | 0.0% | 144 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $12,000 | -42.9% | 144 | -40.0% | 0.00% | -25.0% |
| Q4 2014 | $21,000 | -79.2% | 240 | -81.7% | 0.00% | -55.6% |
| Q4 2013 | $101,000 | +274.1% | 1,310 | +241.1% | 0.01% | +350.0% |
| Q3 2013 | $27,000 | +12.5% | 384 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $24,000 | +9.1% | 384 | +6.7% | 0.00% | 0.0% |
| Q1 2013 | $22,000 | +37.5% | 360 | +25.0% | 0.00% | +100.0% |
| Q4 2012 | $16,000 | +33.3% | 288 | +33.3% | 0.00% | 0.0% |
| Q3 2012 | $12,000 | -98.9% | 216 | -98.5% | 0.00% | -99.1% |
| Q4 2009 | $1,075,000 | +1890.7% | 14,300 | +1330.0% | 0.11% | +1225.0% |
| Q1 2009 | $54,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |